{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T19:18:57Z","timestamp":1758050337617,"version":"3.44.0"},"reference-count":6,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.bulcan.2023.11.003","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T12:31:08Z","timestamp":1702384268000},"page":"129-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Le thiosulfate de sodium en pr\u00e9vention de l\u2019ototoxicit\u00e9 induite par le cisplatine dans la population p\u00e9diatrique ayant une tumeur solide localis\u00e9e"],"prefix":"10.1016","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9758-908X","authenticated-orcid":false,"given":"Arnaud","family":"Saillant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Campedel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bulcan.2023.11.003_bib0035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1470-2045(16)30625-8","article-title":"Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3\u00a0trial","volume":"18","author":"Freyer","year":"2017","journal-title":"Lancet Oncol"},{"issue":"25","key":"10.1016\/j.bulcan.2023.11.003_bib0040","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1056\/NEJMoa1801109","article-title":"Sodium thiosulfate for protection from cisplatin-induced hearing loss","volume":"378","author":"Brock","year":"2018","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.bulcan.2023.11.003_bib0045","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S1470-2045(22)00155-3","article-title":"Sodium thiosulfate for prevention of cisplatin-induced hearing loss: updated survival from ACCL0431","volume":"23","author":"Orgel","year":"2022","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.bulcan.2023.11.003_bib0050","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"Van Driel","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.bulcan.2023.11.003_bib0055","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40463-019-0327-x","article-title":"A randomized controlled trial to test the efficacy of trans-tympanic injections of a sodium thiosulfate gel to prevent cisplatin-induced ototoxicity in patients with head and neck cancer","volume":"48","author":"Rolland","year":"2019","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.bulcan.2023.11.003_bib0030","doi-asserted-by":"crossref","DOI":"10.1097\/MAO.0000000000003069","article-title":"Transtympanic sodium thiosulfate for prevention of cisplatin-induced ototoxicity: a randomized clinical trial","author":"Duinkerken","year":"2021","journal-title":"Otol Neurotol"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455123004381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455123004381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:37:45Z","timestamp":1757792265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455123004381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":6,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0007455123004381"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2023.11.003","relation":{},"ISSN":["0007-4551"],"issn-type":[{"type":"print","value":"0007-4551"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Le thiosulfate de sodium en pr\u00e9vention de l\u2019ototoxicit\u00e9 induite par le cisplatine dans la population p\u00e9diatrique ayant une tumeur solide localis\u00e9e","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2023.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer.","name":"copyright","label":"Copyright"}]}}